Fair Lawn, New Jersey Clinical Trials

A listing of Fair Lawn, New Jersey clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 50 clinical trials
Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

This study will test the safety of Quad Shot radiation therapy using 2 different treatment schedules to find out what effects, if any, this treatment has on people with advanced NSCLC who are receiving systemic therapy for their cancer. The Quad Shot treatment schedule reduces the number of days needed …

pemetrexed
carboplatin
pembrolizumab
paclitaxel
treatment regimen
Memorial Sloan Kettering Bergen (All protocol activities)
 (9.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations
A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia (ATLAS-NEO)

This is a multicenter, multinational, open-label, one-way cross-over, Phase 3, single-arm study for treatment of hemophilia. The purpose of this study is to measure the frequency of treated bleeding episodes with fitusiran in male adult and adolescent (≥12 years old) participants with hemophilia A or B, with or without inhibitory …

Hackensack University Site Number : 8400009
 (4.8 away) Contact site
  • 0 views
  • 24 May, 2024
  • +53 other locations
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer.

endometrial cancer
platinum-based chemotherapy
carboplatin
carboplatin paclitaxel
recurrent endometrial cancer
Research Site
 (3.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +94 other locations
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

carboplatin
stage iiia lung cancer ajcc v7
stage iiia lung squamous cell carcinoma ajcc v7
platelet count
monoclonal antibody therapy
Neurosurgeons of New Jersey-Ridgewood
 (3.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +358 other locations
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Primary Objective: To confirm appropriate dose levels of fitusiran when administered to male pediatric participants (ages 1 to <12 years of age) with severe hemophilia A or B Secondary Objective: To characterize the safety and tolerability To characterize the pharmacokinetics (PK)

bethesda assay
hemophilia
factor ix
haemophilia a
fitusiran
Investigational Site Number 8400008
 (4.8 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +10 other locations
KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated Nonsquamous NSCLC

This is a Phase 2, randomized, multicenter, double-blind study of the glutaminase inhibitor telaglenastat with standard-of-care pembrolizumab and chemotherapy versus placebo with standard-of-care pembrolizumab and chemotherapy for first line treatment of metastatic disease in patients with KEAP1/NRF2-mutated, stage IV, nonsquamous, non-small cell lung cancer (NSCLC). The study primary endpoints are …

carboplatin
pembrolizumab
folic acid
liquid biopsy
STK11
New Jersey Cancer Care and Blood Disorders (NJCCBD)
 (9.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +27 other locations
A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression

Non-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. It is the most common form of lung cancer, accounting for around 85% of lung cancers. The purpose of this study is to evaluate the safety and efficacy …

drug test
pembrolizumab
lymphoma
anaplastic lymphoma
lung cancer
Hackensack Univ Med Ctr /ID# 216484
 (4.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +38 other locations
Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs

The investigators are doing this study to find out whether lowering the dose of postoperative radiation therapy and targeting a smaller area of tissue for treatment is as effective as the standard dose and volume of radiation therapy to control soft tissue sarcoma after surgery. They also want to find …

primary tumor
soft tissue sarcoma
sarcoma
sarcoma of the extremity
serum pregnancy test
Memorial Sloan Kettering Bergen (All protocol activities)
 (9.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations
Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma

The purpose of this study is to find out whether acupuncture treatments can reduce the need for opioid medication when managing pain caused by chemotherapy. The study will compare the effects of adding acupuncture to usual pain management with those of usual pain management alone, in reducing opioid use by …

high-dose chemotherapy
lymphoma
high dose chemotherapy
analgesia
opioid
Hackensack Meridian Health
 (4.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +1 other locations
Double-Blind Multicenter Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19

This clinical trial will examine if a new treatment of Mesenchymal Stems Cells (called PLX-PAD) can help patients intubated and mechanically ventilated due to COVID-19 to recover more quickly with less complications.

SARS
acute respiratory distress
respiratory distress
covid-19
acute respiratory syndrome (sars)
Holy Medical Center
 (6.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +2 other locations